182 related articles for article (PubMed ID: 12077240)
1. Absence of the CD1 molecule up-regulates antitumor activity induced by CpG oligodeoxynucleotides in mice.
Sfondrini L; Besusso D; Zoia MT; Rodolfo M; Invernizzi AM; Taniguchi M; Nakayama T; Colombo MP; Ménard S; Balsari A
J Immunol; 2002 Jul; 169(1):151-8. PubMed ID: 12077240
[TBL] [Abstract][Full Text] [Related]
2. Impaired clearance of herpes simplex virus type 1 from mice lacking CD1d or NKT cells expressing the semivariant V alpha 14-J alpha 281 TCR.
Grubor-Bauk B; Simmons A; Mayrhofer G; Speck PG
J Immunol; 2003 Feb; 170(3):1430-4. PubMed ID: 12538704
[TBL] [Abstract][Full Text] [Related]
3. A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the alpha-galactosylceramide antigen.
Hameg A; Apostolou I; Leite-De-Moraes M; Gombert JM; Garcia C; Koezuka Y; Bach JF; Herbelin A
J Immunol; 2000 Nov; 165(9):4917-26. PubMed ID: 11046017
[TBL] [Abstract][Full Text] [Related]
4. CpG-containing oligodeoxynucleotides act through TLR9 to enhance the NK cell cytokine response to antibody-coated tumor cells.
Roda JM; Parihar R; Carson WE
J Immunol; 2005 Aug; 175(3):1619-27. PubMed ID: 16034101
[TBL] [Abstract][Full Text] [Related]
5. Enhanced tumor-specific long-term immunity of hemagglutinating [correction of hemaggluttinating] virus of Japan-mediated dendritic cell-tumor fused cell vaccination by coadministration with CpG oligodeoxynucleotides.
Hiraoka K; Yamamoto S; Otsuru S; Nakai S; Tamai K; Morishita R; Ogihara T; Kaneda Y
J Immunol; 2004 Oct; 173(7):4297-307. PubMed ID: 15383558
[TBL] [Abstract][Full Text] [Related]
6. Differential regulation of cytokine production by CD1d-restricted NKT cells in response to superantigen staphylococcal enterotoxin B exposure.
Ragin MJ; Sahu N; August A
Infect Immun; 2006 Jan; 74(1):282-8. PubMed ID: 16368982
[TBL] [Abstract][Full Text] [Related]
7. CpG oligonucleotides can prophylactically immunize against Th2-mediated schistosome egg-induced pathology by an IL-12-independent mechanism.
Chiaramonte MG; Hesse M; Cheever AW; Wynn TA
J Immunol; 2000 Jan; 164(2):973-85. PubMed ID: 10623847
[TBL] [Abstract][Full Text] [Related]
8. CpG ODN enhance antigen-specific NKT cell activation via plasmacytoid dendritic cells.
Marschner A; Rothenfusser S; Hornung V; Prell D; Krug A; Kerkmann M; Wellisch D; Poeck H; Greinacher A; Giese T; Endres S; Hartmann G
Eur J Immunol; 2005 Aug; 35(8):2347-57. PubMed ID: 16025562
[TBL] [Abstract][Full Text] [Related]
9. Liposome-encapsulated CpG oligodeoxynucleotides as a potent adjuvant for inducing type 1 innate immunity.
Suzuki Y; Wakita D; Chamoto K; Narita Y; Tsuji T; Takeshima T; Gyobu H; Kawarada Y; Kondo S; Akira S; Katoh H; Ikeda H; Nishimura T
Cancer Res; 2004 Dec; 64(23):8754-60. PubMed ID: 15574787
[TBL] [Abstract][Full Text] [Related]
10. CpG-oligodeoxynucleotides enhance T-cell receptor-triggered interferon-gamma production and up-regulation of CD69 via induction of antigen-presenting cell-derived interferon type I and interleukin-12.
Kranzer K; Bauer M; Lipford GB; Heeg K; Wagner H; Lang R
Immunology; 2000 Feb; 99(2):170-8. PubMed ID: 10692033
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of CD1d expression restores the immunoregulatory function of NKT cells and prevents autoimmune diabetes in nonobese diabetic mice.
Falcone M; Facciotti F; Ghidoli N; Monti P; Olivieri S; Zaccagnino L; Bonifacio E; Casorati G; Sanvito F; Sarvetnick N
J Immunol; 2004 May; 172(10):5908-16. PubMed ID: 15128771
[TBL] [Abstract][Full Text] [Related]
12. A novel function of Valpha14+CD4+NKT cells: stimulation of IL-12 production by antigen-presenting cells in the innate immune system.
Tomura M; Yu WG; Ahn HJ; Yamashita M; Yang YF; Ono S; Hamaoka T; Kawano T; Taniguchi M; Koezuka Y; Fujiwara H
J Immunol; 1999 Jul; 163(1):93-101. PubMed ID: 10384104
[TBL] [Abstract][Full Text] [Related]
13. CD1d-restricted NKT cells: an interstrain comparison.
Hammond KJ; Pellicci DG; Poulton LD; Naidenko OV; Scalzo AA; Baxter AG; Godfrey DI
J Immunol; 2001 Aug; 167(3):1164-73. PubMed ID: 11466330
[TBL] [Abstract][Full Text] [Related]
14. CpG-Oligodeoxynucleotides activate tyrosinase-related protein 2-specific T lymphocytes but do not lead to a protective tumor-specific memory response.
Sfondrini L; Besusso D; Bronte V; Macino B; Rossini A; Colombo MP; Ménard S; Balsari A
Cancer Immunol Immunother; 2004 Aug; 53(8):697-704. PubMed ID: 15034674
[TBL] [Abstract][Full Text] [Related]
15. Injury-induced suppression of effector T cell immunity requires CD1d-positive APCs and CD1d-restricted NKT cells.
Palmer JL; Tulley JM; Kovacs EJ; Gamelli RL; Taniguchi M; Faunce DE
J Immunol; 2006 Jul; 177(1):92-9. PubMed ID: 16785503
[TBL] [Abstract][Full Text] [Related]
16. Deficiency of invariant V alpha 14 natural killer T cells decreases atherosclerosis in LDL receptor null mice.
Rogers L; Burchat S; Gage J; Hasu M; Thabet M; Willcox L; Ramsamy TA; Whitman SC
Cardiovasc Res; 2008 Apr; 78(1):167-74. PubMed ID: 18192239
[TBL] [Abstract][Full Text] [Related]
17. Intratumor CpG-oligodeoxynucleotide injection induces protective antitumor T cell immunity.
Lonsdorf AS; Kuekrek H; Stern BV; Boehm BO; Lehmann PV; Tary-Lehmann M
J Immunol; 2003 Oct; 171(8):3941-6. PubMed ID: 14530311
[TBL] [Abstract][Full Text] [Related]
18. IL-7 up-regulates IL-4 production by splenic NK1.1+ and NK1.1- MHC class I-like/CD1-dependent CD4+ T cells.
Hameg A; Gouarin C; Gombert JM; Hong S; Van Kaer L; Bach JF; Herbelin A
J Immunol; 1999 Jun; 162(12):7067-74. PubMed ID: 10358149
[TBL] [Abstract][Full Text] [Related]
19. An anti-inflammatory role for V alpha 14 NK T cells in Mycobacterium bovis bacillus Calmette-Guérin-infected mice.
Dieli F; Taniguchi M; Kronenberg M; Sidobre S; Ivanyi J; Fattorini L; Iona E; Orefici G; De Leo G; Russo D; Caccamo N; Sireci G; Di Sano C; Salerno A
J Immunol; 2003 Aug; 171(4):1961-8. PubMed ID: 12902499
[TBL] [Abstract][Full Text] [Related]
20. Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells.
Metelitsa LS; Naidenko OV; Kant A; Wu HW; Loza MJ; Perussia B; Kronenberg M; Seeger RC
J Immunol; 2001 Sep; 167(6):3114-22. PubMed ID: 11544296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]